The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
First immunotherapy regimen before and after surgery to extend survival in bladder cancer
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
Combined entity is better positioned to compete in increasingly competitive generics industry
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
Renews GMP certifications for India and Malaysia sites
Approval based on CAPItello-291 results which showed this combination reduced the risk of disease progression or death by 50% vs. Faslodex alone in a biomarker-altered population
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
Subscribe To Our Newsletter & Stay Updated
